AGMB AgomAb Therapeutics NV
NEUTRAL
Impact: 2/10
PRESS-RELEASE
Press release: announcement
Latest settled — T+5d
AGMB ▲ +2.83% at T+5d
NEUTRAL call ✓ call won +2.83% · α vs SPY +2.36% · entry $11.67 → $12.00
Currently $9.61 · -17.65% from $11.67 entry
T+1d
-1.11%
call -1.11% · α -1.67%
$11.54
settled 16d ago
T+5d
+2.83%
call +2.83% · α +2.36%
$12.00
settled 10d ago
T+20d
—
call — · α —
—
in 12d
T+60d
—
call — · α —
—
in 2mo
Price Chart
Loading chart...
Executive Summary
Agomab Therapeutics held its Annual General Meeting on May 26, 2026. The press release announces the meeting results but provides no financial data, guidance, or material business developments. This is a routine corporate governance event with no actionable trading information.
Actionable Insight
No trading implications from this filing. Monitor for future press releases regarding pipeline updates, clinical trial results, or financial performance.
Key Facts
- Annual General Meeting held on May 26, 2026
- No financial results, guidance, or material business updates disclosed
- Routine governance event with no stock-moving content
Financial Impact
No financial impact disclosed
Risk Factors
- No material risks disclosed in this filing
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3301675 |
4 reports for AGMB
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 27, 2026
17d ago
|
Press Release
| $11.67 $12.00 | ▲ +2.83% | ▲ +2.36% | $9.61 (−17.65%) |
|
May 14, 2026
4w ago
|
Press Release
| $11.04 $10.94 | ▼ −0.91% | ▼ −0.19% | $9.61 (−12.95%) |
|
Apr 24, 2026
7w ago
|
6-K
| $11.32 $12.11 | ▲ +6.98% | ▲ +6.58% | $9.61 (−15.11%) |
|
Mar 26, 2026
11w ago
|
Press Release
| $11.87 $10.72 | ▼ −9.69% | ▼ −11.32% | $9.61 (−19.04%) |
Showing 4 of 4
US Market Status
Market Closed — Opens Mon (48h 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access